Article information
Abstract
Highly active antiretroviral therapy (HAART) has changed the morbidity pattern affecting HIV-infected individuals to include non-AIDS-defining cancers. We describe the breast cancer cases occurring in a cohort of 860 HIV-infected women followed in Rio de Janeiro, Brazil, and estimate the incidence rate of breast cancer for this population. Nine cases were identified; median age at diagnosis was 46 years. Median survival after breast cancer diagnosis was 12 months. Breast cancer diagnosis was made within 2 to 15 years of HIV-infection diagnosis. At breast cancer diagnosis, CD4 counts ranged from 135 to 782 cells/mm3; six women were receiving HAART. Histological analysis indicated infiltrating ductal carcinoma in all cases. The incidence rate of breast cancer was 133 cases per 100,000 persons-year. Patients from our case series were late diagnosed with breast cancer and thus suffered from worse prognosis. Strategies targeting earlier diagnosis and prompt initiation of treatment are needed.
Keywords:
HIV
breast neoplasms
case reports
incidence
Full text is only available in PDF
References
[1.]
N. Crum-Cianflone, K.H. Hullsiek, V. Marconi, et al.
Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
AIDS, 23 (2009), pp. 41-50
[2.]
J.E. Sackoff, D.B. Hanna, M.R. Pfeiffer, L.V. Torian.
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.
Ann Intern Med, 145 (2006), pp. 397-406
[3.]
M.J. Silverberg, D.I. Abrams.
AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era.
Curr Opin Oncol, 19 (2007), pp. 446-451
[4.]
B. Marin, R. Thiebaut, H.C. Bucher, et al.
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
AIDS, 23 (2009), pp. 1743-1753
[6.]
J.J. Goedert, C. Schairer, T.S. McNeel, N.A. Hessol, C.S. Rabkin, E.A. Engels.
Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS.
Br J Cancer, 95 (2006), pp. 642-648
[7.]
M. Herida, M. Mary-Krause, R. Kaphan, et al.
Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.
J Clin Oncol, 21 (2003), pp. 3447-3453
[8.]
S.M. Mbulaiteye, R.J. Biggar, J.J. Goedert, E.A. Engels.
Immune deficiency and risk for malignancy among persons with AIDS.
J Acquir Immune Defic Syndr, 32 (2003), pp. 527-533
[9.]
L. Pantanowitz, J.L. Connolly.
Pathology of the breast associated with HIV/AIDS.
Breast J, 8 (2002), pp. 234-243
[10.]
I.A. Voutsadakis, L.R. Silverman.
Breast cancer in HIV-positive women: a report of four cases and review of the literature.
Cancer Invest, 20 (2002), pp. 452-457
[11.]
Oluwole SF, Ali AO, Shafaee Z, DePaz HA. Breast cancer in women with HIV/AIDS: report of five cases with a review of the literature. J Surg Oncol 200; 89:23–7.
[12.]
J. Hurley, S. Franco, C. Gomez-Fernandez, et al.
Breast cancer and human immunodeficiency virus: a report of 20 cases.
Clin Breast Cancer, 2 (2001), pp. 215-220
[13.]
Z. Ashraff, S. Nallamala.
Breast cancer in a woman with HIV/AIDS: case report and review of literature.
J HIV Ther, 12 (2007), pp. 71-72
[14.]
B.F. El-Rayes, K. Berenji, P. Schuman, P.A. Philip.
Breast cancer in women with human immunodeficiency virus infection: implications for diagnosis and therapy.
Breast Cancer Res Treat, 76 (2002), pp. 111-116
[15.]
INCA. Estimativas 2008: Incidência do Câncer no Brasil. Coordenação de Prevenção e Vigilância do Câncer. Instituto Nacional do Câncer. Secretaria de Atenção à Saúde. Ministério da Saúde. Brasil. Rio de Janeiro, 2007.
[16.]
C. Brito, M.C. Portela, M.T. Vasconcellos.
Survival of breast cancer women in the state of Rio de Janeiro, Southeastern Brazil.
Rev Saude Publica, 43 (2009), pp. 481-489
[17.]
M.C. Rezende, H.A. Koch, A. Figueiredo Jde, L.C. Thuler.
Factors leading to delay in obtaining definitive diagnosis of suspicious lesions for breast cancer in a dedicated health unit in Rio de Janeiro.
Rev Bras Ginecol Obstet, 31 (2009), pp. 75-81
[18.]
B. Grinsztejn, F.I. Bastos, V.G. Veloso, R.K. Friedman, J.H. Pilotto, M. Schechter, M. Derrico, A. Andrade, M.C. Lourenco, et al.
Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, Brazil.
Int J STD AIDS, 17 (2006), pp. 473-478
[19.]
B. Grinsztejn, V.G. Veloso, J.E. Levi, et al.
Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women.
Int J Infect Dis, 13 (2009), pp. 72-80
[20.]
Luz PM, Velasque L, Friedman RK et al. Cervical cytological abnormalities and factors associated with high-grade squamous intra-epithelial lesions among HIV-infected women from Rio de Janeiro, Brazil. Int J STD AIDS. Accepted.
[21.]
E.Y. Chiao, S.E. Krown.
Update on non-acquired immunodeficiency syndrome-defining malignancies.
Curr Opin Oncol, 15 (2003), pp. 389-397
[22.]
M.S. Shiels, S.R. Cole, G.D. Kirk, C. Poole.
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals.
J Acquir Immune Defic Syndr, 52 (2009), pp. 611-622
[23.]
Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA 201; 285:1736-45.
[24.]
H. Amir, E.E. Kaaya, G. Kwesigabo, J.N. Kiitinya.
Breast cancer before and during the AIDS epidemic in women and men: a study of Tanzanian Cancer Registry Data 1968 to 1996.
J Natl Med Assoc, 92 (2000), pp. 301-305
[25.]
N.A. Hessol, E.C. Seaberg, S. Preston-Martin, et al.
Cancer risk among participants in the womens interagency HIV study.
J Acquir Immune Defic Syndr, 36 (2004), pp. 978-985
[26.]
L. Pantanowitz, B.J. Dezube.
Reasons for a deficit of breast cancer among HIV-infected patients.
J Clin Oncol, 22 (2004), pp. 1347-1348
[27.]
J. Morgan, J. Gladson, K. Rau.
Position paper of the American council on science and health on risk factors for breast cancer: established, speculated, and unsupported.
The Breast Journal, 4 (1998), pp. 177-197
[28.]
J. Lester.
Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.
Clin J Oncol Nurs, 11 (2007), pp. 619-622
[29.]
M.A. Richards, A.M. Westcombe, S.B. Love, P. Littlejohns, A.J. Ramirez.
Influence of delay on survival in patients with breast cancer: a systematic review.
Lancet, 353 (1999), pp. 1119-1126
[30.]
S.N. Anyanwu.
Temporal trends in breast cancer presentation in the third world.
J Exp Clin Cancer Res, 27 (2008), pp. 17
[31.]
L.C. Thuler, G. Mendonça.
Initial staging of breast and cervical cancer in Brazilian women.
Rev Bras Ginecol Obstet, 27 (2005), pp. 650-660
[32.]
L.H. Gebrim.
Breast cancer screening and stage at diagnosis.
Rev Bras Ginecol Obstet, 31 (2009), pp. 216-218
[33.]
S. Preston-Martin, L.M. Kirstein, J.M. Pogoda, et al.
Use of mammographic screening by HIV-infected women in the Womens Interagency HIV Study (WIHS).
Prev Med, 34 (2002), pp. 386-392
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
